S&P 500
(-0.88%) 4 967.23 points
Dow Jones
(0.56%) 37 986 points
Nasdaq
(-2.05%) 15 282 points
Oil
(0.62%) $83.24
Gas
(0.17%) $1.760
Gold
(0.36%) $2 406.70
Silver
(1.29%) $28.75
Platinum
(-1.17%) $943.30
USD/EUR
(-0.14%) $0.938
USD/NOK
(-0.28%) $11.01
USD/GBP
(0.55%) $0.808
USD/RUB
(-0.96%) $93.00

Realtime updates for Perfect Holding SA [PRFN.SW]

Exchange: SIX Industry: Transportation
Last Updated31 Dec 1970 @ 19:00

-8.12% CHF 0.0362

Live Chart Being Loaded With Signals

Commentary (31 Dec 1970 @ 19:00):

Perfect Holding SA, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapeutics for the treatment of viral, respiratory, and ophthalmic diseases...

Stats
Today's Volume 2.94M
Average Volume 859 130
Market Cap 0.00
Last Dividend CHF0 ( N/A )
Next Dividend CHF0 ( N/A )
P/E -36.20
ATR14 CHF0 (0.00%)

Perfect Holding SA Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Perfect Holding SA Financials

Annual 2021
Revenue: CHF0.00
Gross Profit: CHF0.00 (0.00 %)
EPS: CHF-0.000850
Q2 2019
Revenue: CHF4.33M
Gross Profit: CHF138 000 (3.19 %)
EPS: CHF-0.00125
Q1 2019
Revenue: CHF4.33M
Gross Profit: CHF138 000 (3.19 %)
EPS: CHF-0.00125
Q1 2019
Revenue: CHF4.33M
Gross Profit: CHF138 000 (3.19 %)
EPS: CHF-0.00125

Financial Reports:

No articles found.

Perfect Holding SA

Perfect Holding SA, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapeutics for the treatment of viral, respiratory, and ophthalmic diseases. Its therapeutic drug candidate is KIN001, an advanced clinical stage p38 MAPK inhibitor combined with a marketed drug together enabling an oral long-term treatment for patients suffering from diseases. The company is based in Lausanne, Switzerland.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators